No.

Publication Date

Citing Article

1

2025

Zhijun Ding, Yi Li, Cheng Zhong. Integrated RNA sequencing reveals tumor microenvironment heterogeneity and immunosuppressive role of M2 macrophages in osteosarcoma, Oncologie. 2025; 27: 759.  https://doi.org/10.1515/oncologie-2025-0225

2

2026

Giulia Bagnato, Barbara Peruzzi. Lamins’ role in osteosarcoma, Frontiers in Cell and Developmental Biology. 2026; 14: 1783487.  https://doi.org/10.3389/fcell.2026.1783487

3

2026

Yeongji Kim, Jin-Woo Kim, Junwon Choi, Jinhyeong Kim, Soyeon Park, Wonji Choi, Hyunju An, Jinman Kim, Minsup Kim, Sujin Choi, Jinsu Lim, Hyun Il Lee, Soonchul Lee. PROTAC-Mediated Targeted Degradation of MDM2 Induces Tumor-Suppressive Signaling in Osteosarcoma Cells, Cells. 2026; 15: 473.  https://doi.org/10.3390/cells15050473

4

2025

Nader Shakibazad, Mahdi Shahriari, Mani Ramzi. Breaking the barrier: a guidelines-based review of antiangiogenesis drug resistance in pediatric cancer therapy, Clinical and Experimental Pediatrics. 2025;   https://doi.org/10.3345/cep.2025.01809

5

2025

Peng Liang, Yan Li, Peipei Feng, Sirong Wei. Advancing bone tumor detection in older adults: the impact of AI-enhanced medical imaging, Frontiers in Medicine. 2025; 12: 1697975.  https://doi.org/10.3389/fmed.2025.1697975

6

2026

Valentina Kottmann, Michael Nienhaus, Philipp Drees, Erol Gercek, Ulrike Ritz. From bone homeostasis to skeletal metastasis and osteosarcoma: Insights into osteoclast and osteoblast roles in bone remodelling and cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026; 1881: 189551189551.  https://doi.org/10.1016/j.bbcan.2026.189551

7

2026

Paulraj, S., First-Line Application of Open Biopsy Method in Osteosarcoma Prognosis - The Contraindications, Journal of Surgery and Surgical Procedures. 2026; 91.  https://doi.org/10.47485/3069-8154.1027

8

2026

Kavitha Unnikrishnan, Abhay Mahesh, Ram Mohan Ram Kumar. Therapeutic Exosomes for Rare Cancers: Advances and Clinical Translation, ChemMedChem. 2026; 21: e202500653.  https://doi.org/10.1002/cmdc.202500653

9

2026

Hongyuan Liu, Guobing Wang, Chunxue Wang, Dan Hou, Shigang Li, Yuansheng Fan, Bing Liu. Neurotrophin NGF/TrkA and BDNF/TrkB signaling orchestrates the immune microenvironment in osteosarcoma, Frontiers in Immunology. 2026; 16: 1727434.  https://doi.org/10.3389/fimmu.2025.1727434

10

2026

Daniele Bellavia, Flores Naselli, Graziella Serio, Paola Miriam Russo, Viviana Costa, Angela De Luca, Lavinia Raimondi, Carla Gentile, Fabio Caradonna, Gianluca Giavaresi. Antimetastatic Effects of a Griffonia simplicifolia Seed Extract in Osteosarcoma Cell Lines, Antioxidants. 2026; 15: 263.  https://doi.org/10.3390/antiox15020263

11

2026

Victória Dogani Rodrigues, Cláudia Rucco Penteado Detregiachi, Manuela dos Santos Bueno, Luíza Santos de Argollo Haber, Rachel Gomes Eleutério, Eliana de Souza Bastos Mazuqueli Pereira, Virgínia Maria Cavallari Strozze Catharin, Lidiane Indiani, Vitor Cavallari Strozze Catharin, Sérgio Zabotto Dantas, Kátia Portero Sloan, Caio Sergio Galina Spilla, Lance Alan Sloan, Karina Quesada, Sandra Maria Barbalho, Lucas Fornari Laurindo. Imperatorin: A Furanocoumarin with Potential in Combating Cancer Development and Progression—A Comprehensive Review, Pharmaceuticals. 2026; 19: 436.  https://doi.org/10.3390/ph19030436

12

2026

Zi-Yu Chen, Miersalijiang Yasen, Song-Yao Jiang, Zi-Yi Ye, Qin-Xin Yang, Cui-Ni Lu, Yi Shi, Xin-Yun Liu, Ting-Ting Du, Xiao-Mei Tang, Da Fu, Yu-Shui Ma, Hong Yu, Xiao-Feng Wang. TMEM158-mediated TGF-β signaling pathway modulates the sensitivity of TP53-deficient osteosarcoma to USP14 inhibitors, Molecular and Cellular Biochemistry. 2026;   https://doi.org/10.1007/s11010-026-05487-0

13

2025

Alessandro El Motassime, Raffaele Vitiello, Rocco Maria Comodo, Giacomo Capece, Guido Bocchino, Maria Beatrice Bocchi, Giulio Maccauro, Cesare Meschini. Osteosarcoma: A Comprehensive Morphological and Molecular Review with Prognostic Implications, Biology. 2025; 14: 1407.  https://doi.org/10.3390/biology14101407